Much of the conversation at THT revolved around how use of the device would be handled outside of specialized centers.

It's a medical device that is already being put to good use, with the Shoreline team having already implanted the device in a ...

WARRINGTON, Pa. - Windtree Therapeutics, Inc. (NASDAQ:WINT), a biotechnology firm specializing in the development of therapies for critical diseases and currently valued at $1.44 million market ...

Doctor reveals the #1 mistake people make during a heart attack and suggests the best treatment option that can save your ...

Windtree Therapeutics (WINT) announced that an istaroxime presentation featuring the positive Phase 2b SEISMiC study was given on February 11, ...

Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...